P
Peter L. Gross
Researcher at McMaster University
Publications - 126
Citations - 7329
Peter L. Gross is an academic researcher from McMaster University. The author has contributed to research in topics: Platelet & Platelet activation. The author has an hindex of 41, co-authored 120 publications receiving 6359 citations. Previous affiliations of Peter L. Gross include McMaster-Carr & Harvard University.
Papers
More filters
Journal ArticleDOI
Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin
Shahrokh Falati,Qingde Liu,Peter L. Gross,Glenn Merrill-Skoloff,Janet Ing-Yuh Chou,Erik Vandendries,Alessandro Celi,Kevin Croce,Barbara C. Furie,Bruce Furie +9 more
TL;DR: It is proposed that PSGL-1 plays a role in blood coagulation in addition to its known role in leukocyte trafficking by examining thrombus formation in the microcirculation of wild-type and genetically altered mice by real-time in vivo microscopy.
Journal ArticleDOI
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.
TL;DR: This system provides high-speed, near-simultaneous acquisition of images of multiple fluorescent probes and of a brightfield channel that observed platelet deposition, tissue factor accumulation and fibrin generation after laser-induced endothelial injury in a single developing thrombus.
Journal ArticleDOI
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier,Karim Abou-Nassar,Ranjeeta Mallick,Vicky Tagalakis,Sudeep Shivakumar,Ariah Schattner,Philip Kuruvilla,Danny Hill,Silvana Spadafora,Katerine Marquis,Mateya Trinkaus,Anna Tomiak,Agnes Y.Y. Lee,Peter L. Gross,Alejandro Lazo-Langner,Robert El-Maraghi,Glenwood D. Goss,Grégoire Le Gal,David J. Stewart,Tim Ramsay,Marc A. Rodger,Debra Witham,Philip S. Wells,Avert Investigators +23 more
TL;DR: Apixaban therapy resulted in a significantly lower rate of venous thromboembolism than did placebo among intermediate‐to‐high‐risk ambulatory patients with cancer who were starting chemotherapy.
Journal ArticleDOI
A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals
Deborah S. Yokoe,Leonard A. Mermel,Deverick J. Anderson,Kathleen M. Arias,Helen Burstin,David P. Calfee,Susan E. Coffin,Erik R. Dubberke,Victoria J. Fraser,Dale N. Gerding,Frances A. Griffin,Peter L. Gross,Keith S. Kaye,Michael Klompas,Evelyn Lo,Jonas Marschall,Lindsay E. Nicolle,David A. Pegues,Trish M. Perl,Kelly Podgorny,Sanjay Saint,Cassandra D. Salgado,Robert A. Weinstein,Robert J. Wise,David C. Classen +24 more
TL;DR: This compendium is implementation focused and differs from most previously published guidelines in that it highlights a set of basic HAI prevention strategies plus special approaches for use in locations and/or populations within the hospital when infections are not controlled by use of basic practices.
Journal ArticleDOI
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
James D. Douketis,Alex C. Spyropoulos,Joanne Duncan,Marc Carrier,Grégoire Le Gal,Alfonso Tafur,Thomas Vanassche,Peter Verhamme,Sudeep Shivakumar,Peter L. Gross,Agnes Y.Y. Lee,Erik Yeo,Susan Solymoss,Jeannine Kassis,Geneviève Le Templier,Stephen Kowalski,Mark Blostein,Vinay Shah,Elizabeth MacKay,Cynthia Wu,Nathan P. Clark,Shannon M. Bates,Frederick A. Spencer,Eleni Arnaoutoglou,Michiel Coppens,Donald M. Arnold,Joseph A. Caprini,Na Li,Karen A. Moffat,Summer Syed,Sam Schulman +30 more
TL;DR: Patients with atrial fibrillation who had DOAC therapy interruption for elective surgery or procedure, a perioperative management strategy without heparin bridging or coagulation function testing was associated with low rates of major bleeding and arterial thromboembolism.